Traitements4programmes
Essais2liés
Publications0liées
SourceDBlocale

Traitements

4
MoléculeIndication / populationPhaseObjectifPaysRésultat
NIDBase — National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaThe aim of this study is to establish a real-world clinical neuroimmune disease research cohort, to follow up and observe the prognosis of patients with different subtypes and subgroups, and to provide support for the treatment, early warning, and outcome prediction research of neuroimmune diseases. SEP À vérifier China À vérifier
TIE — Temporal Interference for Drug Resistant EpilepsyThis single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60. Épilepsie Non applicable À vérifier China À vérifier
NIDBase — National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaThe aim of this study is to establish a real-world clinical neuroimmune disease research cohort, to follow up and observe the prognosis of patients with different subtypes and subgroups, and to provide support for the treatment, early warning, and outcome prediction research of neuroimmune diseases. SEP À vérifier China À vérifier
TIE — Temporal Interference for Drug Resistant EpilepsyThis single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60. Épilepsie Non applicable À vérifier China À vérifier

Essais cliniques

2
MoléculeIndication / populationPhaseNCTTitreStatut
TIE — Temporal Interference for Drug Resistant Epilepsy Épilepsie Non applicable NCT06708143 TIE — Temporal Interference for Drug Resistant Epilepsy RECRUITING
NIDBase — National, Multicentric Registry Study on Neuroimmunological Diseases in China SEP À vérifier NCT06443333 NIDBase — National, Multicentric Registry Study on Neuroimmunological Diseases in China UNKNOWN

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.